Variant report
Variant | nsv528372 |
---|---|
Chromosome Location | chr3:151210190-151218277 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr3:151212728-151212825 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOXP2 | chr3:151216764-151216988 | SK-N-MC | brain: | n/a | n/a |
3 | MAX | chr3:151213789-151213980 | K562 | blood: | n/a | chr3:151213921-151213932 chr3:151213923-151213932 |
4 | MYC | chr3:151212852-151213032 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | POLR2A | chr3:151214162-151214290 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | POLR2A | chr3:151216645-151217184 | SK-N-MC | brain: | n/a | n/a |
7 | POLR2A | chr3:151218043-151218163 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr3:151214150-151214278 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | RXRA | chr3:151214150-151214299 | HepG2 | liver: | n/a | n/a |
10 | SP1 | chr3:151214082-151214319 | HepG2 | liver: | n/a | n/a |
11 | STAT3 | chr3:151211362-151211546 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | STAT3 | chr3:151217537-151217580 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr3:151213152-151213308 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | ZBTB33 | chr3:151214134-151214313 | HepG2 | liver: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000242119 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9876367 | chr3:151210190-151210191 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs546966928 | chr3:151210191-151210192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567179584 | chr3:151210200-151210201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188321138 | chr3:151210206-151210207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574885027 | chr3:151210247-151210248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541923986 | chr3:151210269-151210270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377112401 | chr3:151210276-151210277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558981644 | chr3:151210293-151210294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111281977 | chr3:151210304-151210305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538042538 | chr3:151210326-151210327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554261778 | chr3:151210358-151210359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561156282 | chr3:151210375-151210376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9838789 | chr3:151210388-151210389 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs191616406 | chr3:151210416-151210417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184249745 | chr3:151210438-151210439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7631871 | chr3:151210452-151210453 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs149702937 | chr3:151210461-151210462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562623955 | chr3:151210462-151210463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531548267 | chr3:151210479-151210480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116758779 | chr3:151210489-151210490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201351841 | chr3:151210533-151210534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368762917 | chr3:151210534-151210535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142364842 | chr3:151210535-151210536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs150976240 | chr3:151210541-151210542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs397789656 | chr3:151210545-151210546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561368883 | chr3:151210552-151210553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530174717 | chr3:151210556-151210557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs55889781 | chr3:151210566-151210567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370865004 | chr3:151210567-151210568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs397936195 | chr3:151210570-151210571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs56168503 | chr3:151210577-151210578 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs202239363 | chr3:151210716-151210717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146426721 | chr3:151210723-151210724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182114304 | chr3:151210727-151210728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566916041 | chr3:151210747-151210748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532384042 | chr3:151210759-151210760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552871074 | chr3:151210768-151210769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185478153 | chr3:151210855-151210856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538456150 | chr3:151210938-151210939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537212513 | chr3:151210964-151210965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs79391033 | chr3:151211011-151211012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533682075 | chr3:151211030-151211031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190832069 | chr3:151211038-151211039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576805754 | chr3:151211107-151211108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545447384 | chr3:151211141-151211142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563720495 | chr3:151211160-151211161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs180833981 | chr3:151211176-151211177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576209983 | chr3:151211198-151211199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565932955 | chr3:151211242-151211243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140108310 | chr3:151211267-151211268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 16773561 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:151209400-151213000 | Weak transcription | Ovary | ovary |
2 | chr3:151213000-151213600 | Enhancers | Ovary | ovary |
3 | chr3:151216400-151217200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr3:151216400-151217400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr3:151216400-151217400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr3:151216600-151217200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr3:151216800-151217000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr3:151216800-151217400 | Enhancers | Fetal Lung | lung |
9 | chr3:151217200-151217800 | Enhancers | Ovary | ovary |
10 | chr3:151217200-151218400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
11 | chr3:151217200-151218600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr3:151217400-151218400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr3:151217400-151219200 | Weak transcription | Fetal Lung | lung |
14 | chr3:151217400-151219600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr3:151217800-151218200 | Weak transcription | Ovary | ovary |
16 | chr3:151218200-151219000 | Enhancers | Ovary | ovary |